BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34821406)

  • 21. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SS18-SSX Antibody: A Useful Tool to Save Time and Reduce Costs in Synovial Sarcoma Diagnosis. Proposal of a Novel Diagnostic Algorithm.
    Orlando G; Santoro F; Linari A; Tampieri C; Verdun di Cantogno L; De Meo S; Ratto N; Grignani G; Papotti M; Senetta R
    J Histochem Cytochem; 2023 Jul; 71(7):377-385. PubMed ID: 37357741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
    Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
    PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
    Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.
    Owosho AA; Estilo CL; Rosen EB; Yom SK; Huryn JM; Antonescu CR
    Oral Oncol; 2017 Mar; 66():46-51. PubMed ID: 28249647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual mimicker of odontogenic carcinoma: Primary synovial sarcoma of the temporomandibular joint- a critical role for molecular diagnosis.
    Bell D; Altan M; Gidley PW
    Pathol Res Pract; 2022 Apr; 232():153824. PubMed ID: 35231858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
    Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases.
    Sun B; Sun Y; Wang J; Zhao X; Zhang S; Liu Y; Li X; Feng Y; Zhou H; Hao X
    Cancer Sci; 2008 Jul; 99(7):1355-61. PubMed ID: 18460022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
    Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
    Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Palmerini E; Benassi MS; Quattrini I; Pazzaglia L; Donati D; Benini S; Gamberi G; Gambarotti M; Picci P; Ferrari S
    Orphanet J Rare Dis; 2015 Jan; 10():6. PubMed ID: 25613038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.
    Wakamatsu T; Naka N; Sasagawa S; Tanaka T; Takenaka S; Araki N; Ueda T; Nishizawa Y; Yoshikawa H; Itoh K
    Cancer Sci; 2014 Sep; 105(9):1124-34. PubMed ID: 24975049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and molecular reappraisal of spindle cell adamantinoma of bone reveals a small subset of misclassified intraosseous synovial sarcoma.
    Horvai A; Dashti NK; Rubin BP; Kilpatrick SE; Rudzinski ER; Lopez-Terrada D; Hubley MB; Davis JL; Fritchie K
    Mod Pathol; 2019 Feb; 32(2):231-241. PubMed ID: 30206413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.
    Hiraga H; Nojima T; Abe S; Sawa H; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
    Diagn Mol Pathol; 1998 Apr; 7(2):102-10. PubMed ID: 9785009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.